Omega Medical Imaging First in the World to Receive FDA Clearance on Artificial Intelligence Imaging System That Reduces Dose

SANFORD, Fla., October 15, 2019 (Newswire.com) - Omega Medical Imaging, manufacturers of Artificial Intelligence Fluoroscopy/Cine (AIF/C) Imaging systems, just announced the Food and Drug Administration 510 (k) clearance of FluoroShield™ with their 2020 Cardiac Flat Panel Detector.

The unique FluoroShield™ system allows for auto collimation during interventional fluoro or cine cases while maintaining a perspective of surrounding anatomy. The blended image incorporates a lower frequency refresh of the peripheral image area. This combined image (live fluoroscopy or cine of ROI + background refreshed at a rate of once or twice per second) increases the quality of information presented during interventional procedures. Brian Fleming, President of Omega Medical Imaging states, "Until now products on the market have only been able to manage radiation to patients and staff. FluoroShield™ is the only system in the world that provides an actual reduction in dose. The impact of this groundbreaking solution for patients and healthcare providers is substantial. I am very grateful to be a part of a team that pushes the envelope in the development of safer healthcare solutions."

Benefits of FluoroShield™

• Image quality is improved via auto-collimation resulting in a reduced FOV and subsequently less exposure to harmful X-ray.
• Anatomical landmarks and devices visible outside the Region of Interest (ROI) provide important clinical information which are viewed at a reduced exposure level / Rate.
• Fluoroshield™ can be sized and positioned in manual mode, as opposed to conventional collimation, which is generally limited to positioning about the center of the image.
• Auto ROI automatically follows the movement of devices i.e., catheters, etc., minimizing distraction and input requirements for the operator.

Omega Medical Imaging LLC based in Sanford Florida USA is an innovator in the design, manufacture, delivery, and support of Artificial Intelligence Fluoroscopy/Cine (AIF/C) Imaging systems for hospitals and healthcare facilities around the globe.

To request further information about Omega Medical Imaging, please visit its website at https://www.omegamedicalimaging.com.

Contact:
Megan Grosz
Omega Medical Imaging, LLC.
1-407-323-9400 X212

[email protected]

www.omegamedicalimaging.com

Source: Omega Medical Imaging